Masterclass: Will Digital Twins Define the Next Era of Clinical Trials?

Digital twins are digital replicas of physical objects, systems, or processes. In the context of healthcare, digital twins can be created for various entities, such as patients, organs, medical devices, or even entire healthcare systems. When applied to clinical trials, digital twins have the potential to streamline processes, reduce costs, improve patient outcomes, and overcome ethical issues of placebo arms within clinical research.

The first part of this series “The Future of Digital Twins in Healthcare”, is focused on clarifying what digital twins are, and where their potential lies across the entire healthcare ecosystem. In this session, Benedikt von Thüngen (Founder & CEO, Sanome) will delve deeper into the strategies and capabilities of using digital twins in clinical trials. 

If you are interested in optimising and improving your trial design, don’t miss out on this opportunity to delve into the transformative capabilities of digital twins in the clinical trial setting. This masterclass will walk you through: 

• How digital twins are redefining clinical trial design, and  shaping the future of clinical research. 

• Where digital twins should fit within your clinical trial strategy. 

• How to ensure your clinical trial strategy meets regulatory expectations

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.